A Study to Learn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Moderate Reduced Kidney Function and in Healthy Male and Female Participants With Normal Kidney Function

PHASE1WithdrawnINTERVENTIONAL

Timeline

Start Date

May 15, 2023

Primary Completion Date

August 17, 2023

Study Completion Date

October 12, 2023

Conditions

Diabetic Neuropathic PainRenal ImpairmentHealthy Volunteers

Interventions

DRUG

BAY2395840

Immediate release (IR) tablet, oral administration